A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (16), 2225-2231
- https://doi.org/10.1016/0959-8049(93)90211-w
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1992
- POMBACE chemotherapy in non-seminomatous germ cell tumours: Outcome and importance of dose intensityEuropean Journal Of Cancer, 1992
- Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumoursThe Lancet, 1991
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Disseminated testicular cancer with bulky disease: results of a phase-II study with cisplatin ultra high dose/VP-16/bleomycinInternational Journal of Andrology, 1987
- Prognostic factors in metastatic testicular cancerInternational Journal of Andrology, 1987
- Current Optimum Management of Anaplastic Germ Cell Tumours of the Testis and Other SitesBritish Journal of Urology, 1986
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- VP16-213 as a single agent in advanced testicular tumorsEuropean Journal of Cancer (1965), 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958